APA citiranje

Giordano, F., Vaira, V., Cortinovis, D., Bonomo, S., Goedmakers, J., Brena, F., . . . Grassilli, E. (2019). p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma. J Exp Clin Cancer Res.

Citação norma Chicago

Giordano, Federica, et al. "P65BTK Is a Novel Potential Actionable Target in KRAS-mutated/EGFR-wild Type Lung Adenocarcinoma." J Exp Clin Cancer Res 2019.

MLA citiranje

Giordano, Federica, et al. "P65BTK Is a Novel Potential Actionable Target in KRAS-mutated/EGFR-wild Type Lung Adenocarcinoma." J Exp Clin Cancer Res 2019.